Report Categories
View AllRecent Articles
View All
Ath A Stock Analysis Athene Holding 6.35 Pct Series A Preferred Stays Flat At 100 20260401
Is Intelligent Intj Stock In Consolidation Phase Price At 8.16 Down 14.55 20260408
What Do Insiders Think About Creative Cmct Stock Price At 0.64 Up 27.03 20260407
What Makes Thermo Tmo Stock Attractive Or Not Price At 500.56 Up 0.90 20260413
The moat Ollies OLLI is building for long term dominance Smart Money Outflows 20260508
DNTH Dianthus shares fall 55 after Q4 earnings miss estimates by 30 loss widens to 143 per share
What separates ADSTEC ADSE from the pack Technical Weakness 20260508
NOM Nuveen latest quarterly earnings report carries no consensus comparable metrics as management reaffirms its muni portfolio strategy
UK Government Proposes VAT Reduction for Theme Parks and Childrens Meals to Ease CostofLiving Burden
Consumers Demonstrate Resilience Amid Economic Uncertainty Latest Data Suggests
Healthcare and Tech Lead as Broad Market Edges Higher
Amazon Expands AI Shopping Technology to ThirdParty Retailers Signs Kate Spade as First Customer
Chinas Deadliest Coal Mining Disaster in Years Sparks Public Anger and Safety Concerns
Trump Urges Bank of America JPMorgan to End Alleged Discrimination Against Conservatives
XRTX Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue RD Costs Shares Climb
HireQuest Inc HQI Q1 2026 Earnings EPS Misses Estimate by Narrow Margin Shares Decline
Super Group SGHC Q1 2026 Earnings EPS Misses Estimates as Costs Weigh on Results
Bicara Therapeutics BCAX Q1 2026 Earnings EPS Miss Overshadowed by Pipeline Progress as Stock Rises 4
DMRC Q1 2026 Earnings EPS Surpasses Estimates with 5267 Beat
CMPS Q1 2026 Earnings NarrowerthanExpected Loss Despite Stock Decline
FG Merger II Corp Rights FGMCR Hold Steady at 075 as Rights Trading Consolidates
Erie Indemnity ERIE Shows Modest Decline as Price Consolidates Near Key Support
Cellectis CLLS Stock Dips 127 as Biotech Volatility Persists Key Support at 332 in Focus
Social Commerce Partners Unit SCPQU Surges Nearly 7 as Bulls Test Resistance
ADMA Biologics Slides 109 Key Support Levels in Focus Amid Biotech Headwinds